Biocodex Deal History & Licensing Activity
Biocodex is a life sciences. Over the past three years, Biocodex has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Other
Focus Area
Rare Disease
Biocodex Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Biocodex in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| rare diseases program | THX Pharma | Other | Unknown | license | Feb 2026 |
Biocodex Pipeline Focus
Therapeutic areas and modalities where Biocodex is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Biocodex's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Rare Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Rare Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for rare disease
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Biocodex Licensing & Deal Activity
Biocodex is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Biocodex ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Biocodex include Rare Disease (2 deals and trials). In terms of modality, Biocodex has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Biocodex and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Biocodex's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.